These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12917088)

  • 21. Glucagonoma syndrome. A clinicopathologic, immunocytochemical, and ultrastructural study.
    Vandersteen PR; Scheithauer BW
    J Am Acad Dermatol; 1985 Jun; 12(6):1032-9. PubMed ID: 2989344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term non-surgical therapy of severe persistent congenital hyperinsulinism with glucagon.
    Mohnike K; Blankenstein O; Pfuetzner A; Pötzsch S; Schober E; Steiner S; Hardy OT; Grimberg A; van Waarde WM
    Horm Res; 2008; 70(1):59-64. PubMed ID: 18493152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous infusion of glucagon induces severe hyponatremia and thrombocytopenia in a premature neonate.
    Belik J; Musey J; Trussell RA
    Pediatrics; 2001 Mar; 107(3):595-7. PubMed ID: 11230607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucagonoma presenting as morbid obesity.
    Martin FM; Hamilton W; Dons R; Cashell AW; Ghosh BC
    J Surg Oncol; 1988 Dec; 39(4):256-9. PubMed ID: 2848156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucagonoma syndrome and necrolytic migratory erythema.
    Lobo I; Carvalho A; Amaral C; Machado S; Carvalho R
    Int J Dermatol; 2010 Jan; 49(1):24-9. PubMed ID: 20465606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Necrolytic migratory erythema revealing glucagonoma without diabetes].
    Marty C; Bennet A; Bayle P; Danjoux M; Lalande T; Marguery MC; Bazex J
    Ann Med Interne (Paris); 2003 Dec; 154(8):552-6. PubMed ID: 15037834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Necrolytic migratory erythema with myelodysplastic syndrome without glucagonoma.
    Technau K; Renkl A; Norgauer J; Ziemer M
    Eur J Dermatol; 2005; 15(2):110-2. PubMed ID: 15757825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dermatitis, glossitis, stomatitis, cheilitis, anemia and weight loss: a classic presentation of pancreatic glucagonoma.
    Povoski SP; Zaman SA; Ducatman BS; McFadden DW
    W V Med J; 2002; 98(1):12-4. PubMed ID: 11941895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The glucagonoma syndrome and necrolytic migratory erythema: a clinical review.
    van Beek AP; de Haas ER; van Vloten WA; Lips CJ; Roijers JF; Canninga-van Dijk MR
    Eur J Endocrinol; 2004 Nov; 151(5):531-7. PubMed ID: 15538929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do glucagonomas always produce glucagon?
    Wewer Albrechtsen NJ; Challis BG; Damjanov I; Holst JJ
    Bosn J Basic Med Sci; 2016 Feb; 16(1):1-7. PubMed ID: 26773171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hypoglycemia--a report on 5 patients with insulinoma and 1 with pleural mesothelioma].
    Renar IP; Granić M; Sucić M; Milicević Z; Stulhofer M; Skrabalo Z
    Lijec Vjesn; 1986 May; 108(5):182-5. PubMed ID: 3014241
    [No Abstract]   [Full Text] [Related]  

  • 32. Necrolytic migratory erythema and glucagon cell tumour of the pancreas: the glucagonoma syndrome. Report of two cases.
    Pedersen NB; Jonsson L; Holst JJ
    Acta Derm Venereol; 1976; 56(5):391-5. PubMed ID: 78626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical spectrum of hyperglucagonemia associated with malignant neuroendocrine tumors.
    Wermers RA; Fatourechi V; Kvols LK
    Mayo Clin Proc; 1996 Nov; 71(11):1030-8. PubMed ID: 8917287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The glucagonoma syndrome: a review of its features and discussion of new perspectives.
    Chastain MA
    Am J Med Sci; 2001 May; 321(5):306-20. PubMed ID: 11370794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Necrolytic migratory erythema.
    Kovács RK; Korom I; Dobozy A; Farkas G; Ormos J; Kemény L
    J Cutan Pathol; 2006 Mar; 33(3):242-5. PubMed ID: 16466513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and metabolic aspects of glucagonoma.
    Leichter SB
    Medicine (Baltimore); 1980 Mar; 59(2):100-13. PubMed ID: 6987481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case with glucagonoma syndrome--endocrine and metabolic studies.
    Fukushima H; Yamaguchi K; Uzawa H; Kitoh M; Takemiya M; Konno T
    Endocrinol Jpn; 1981 Apr; 28(2):111-25. PubMed ID: 6273136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Necrolytic Migratory Erythema: Complete Healing after Surgical Removal of Pancreatic Carcinoma.
    V'lckova-Laskoska M; Balabanova-Stefanova M; Arsovska-Bezhoska I; Caca-Biljanovska N; Laskoski D
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):329-332. PubMed ID: 30665484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development.
    Lu J; Herrera PL; Carreira C; Bonnavion R; Seigne C; Calender A; Bertolino P; Zhang CX
    Gastroenterology; 2010 May; 138(5):1954-65. PubMed ID: 20138042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Glucagonoma syndrome in a multihormonal pancreatic tumor].
    Keller U; Fankhauser S; Schumacher A; Trimble ER; Heitz PU
    Schweiz Med Wochenschr; 1982 Feb; 112(9):297-304. PubMed ID: 6281878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.